(Q41293436)

29 September 2017

1 reference

title

Mechanisms of action of interferon-beta in multiple sclerosis (English)

1 reference

29 September 2017

0 references

B G Arnason

1

1 reference

29 September 2017

A Dayal

2

1 reference

29 September 2017

Z X Qu

3

1 reference

29 September 2017

M A Jensen

4

1 reference

29 September 2017

K Genç

5

1 reference

29 September 2017

A T Reder

6

1 reference

29 September 2017

publication date

1 January 1996

1 reference

Seminars in Immunopathology

29 September 2017

published in

1 reference

29 September 2017

volume

18

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

125-148

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00792613

29 September 2017

exact match

0 references

cites work

Suppressor cell function in multiple sclerosis

1 reference

12 December 2020

Eicosenoids Modify Experimental Allergic Encephalomyelitis

1 reference

12 December 2020

Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1

1 reference

12 December 2020

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

1 reference

12 December 2020

Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products

1 reference

12 December 2020

Interferon in experimental autoimmune encephalomyelitis: intraventricular administration

1 reference

12 December 2020

Inhibition of Passive Localized Experimental Allergic Encephalomyelitis by Interferon

1 reference

12 December 2020

Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma

1 reference

12 December 2020

In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes

1 reference

12 December 2020

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

1 reference

12 December 2020

Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis by retinoic acid

1 reference

12 December 2020

Enhancement of monocyte class I and II histocompatibility antigen expression in man by in vivo beta-interferon.

1 reference

12 December 2020

TGF-beta-like activity produced during regression of exacerbations in multiple sclerosis

1 reference

12 December 2020

Interferon-induced skin reactivity in man

1 reference

12 December 2020

Cytokines in neuroinflammatory disease: role of myelin autoreactive T cell production of interferon-gamma

1 reference

12 December 2020

Tumor necrosis factor inhibits K+ current expression in cultured oligodendrocytes.

1 reference

12 December 2020

Modulation of the immune response by transforming growth factor beta

1 reference

12 December 2020

Interferon beta in multiple sclerosis

1 reference

12 December 2020

Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines

1 reference

12 December 2020

Oligodendrocytes in the early course of multiple sclerosis.

1 reference

12 December 2020

The mechanism of inhibition of human IL 2 production

1 reference

12 December 2020

Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells

1 reference

12 December 2020

Interferon Crosses Blood-Cerebrospinal Fluid Barrier in Monkeys

1 reference

12 December 2020

Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients

1 reference

12 December 2020

Validation of the functional assessment of multiple sclerosis quality of life instrument

1 reference

12 December 2020

Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1

1 reference

12 December 2020

Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course

1 reference

12 December 2020

The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course

1 reference

12 December 2020

Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis

1 reference

12 December 2020

Contrasting effects of interferon-gamma and interleukin-4 on neopterin generation from human adherent monocytes

1 reference

12 December 2020

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

1 reference

12 December 2020

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

1 reference

12 December 2020

Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery

1 reference

12 December 2020

Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats

1 reference

12 December 2020

Antagonistic effect of interferon-beta on the interferon-gamma-induced expression of Ia antigen in murine macrophages

1 reference

12 December 2020

Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images

1 reference

12 December 2020

Tumor necrosis factor and IFN induce a common set of proteins

1 reference

12 December 2020

Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions

1 reference

12 December 2020

Trigeminal neuralgia in multiple sclerosis relieved by a prostaglandin E analogue

1 reference

12 December 2020

Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids

1 reference

12 December 2020

IL-4 increases human endothelial cell adhesiveness for T cells but not for neutrophils.

1 reference

12 December 2020

Interferon-beta specifically inhibits interferon-gamma-induced class II major histocompatibility complex gene transcription in a human astrocytoma cell line

1 reference

12 December 2020

Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta

1 reference

12 December 2020

Interleukin-1 stimulation of astroglial proliferation after brain injury.

1 reference

12 December 2020

Beta interferon subtype 1 induction by tumor necrosis factor

1 reference

12 December 2020

Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor

1 reference

12 December 2020

Effects of the prostaglandin analogue misoprostol on inflammatory mediator release by human monocytes

1 reference

12 December 2020

B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

1 reference

12 December 2020

Interferon in experimental autoimmune encephalomyelitis (EAE): effects of exogeneous interferon on the antigen-enhanced adoptive transfer of EAE

1 reference

12 December 2020

Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels

1 reference

12 December 2020

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

12 December 2020

Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors

1 reference

12 December 2020

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

12 December 2020

Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis

1 reference

12 December 2020

T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats

1 reference

12 December 2020

Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes

1 reference

12 December 2020

Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity

1 reference

12 December 2020

Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.

1 reference

12 December 2020

Interferon-mediated inhibition of prostaglandin synthesis in human mononuclear leukocytes

1 reference

12 December 2020

In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta

1 reference

12 December 2020

Immunopharmacologic modulation of experimental allergic encephalomyelitis: low-dose cyclosporin-A treatment causes disease relapse and increased systemic T and B cell-mediated myelin-directed autoimmunity

1 reference

12 December 2020

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

1 reference

12 December 2020

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

1 reference

12 December 2020

The role of cytokines in various animal models of inflammation.

1 reference

12 December 2020

Tumor necrosis factor identified in multiple sclerosis brain

1 reference

12 December 2020

Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells

1 reference

12 December 2020

Relative increase of inflammatory CD4+ T cells in the cerebrospinal fluid of multiple sclerosis patients and control individuals

1 reference

12 December 2020

Involvement of cytokines in acute neurodegeneration in the CNS.

1 reference

12 December 2020

Exacerbations of multiple sclerosis in patients treated with gamma interferon

1 reference

12 December 2020

Neopterin augmentation of tumor necrosis factor production

1 reference

12 December 2020

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis.

1 reference

12 December 2020

ICAM-1-independent lymphocyte transmigration across high endothelium : Differential up-regulation by interferon γ, tumor necrosis factor-α and interleukin 1β

1 reference

12 December 2020

Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma

1 reference

12 December 2020

CD4+ suppressor cells differentially affect the production of IFN-gamma by effector cells of experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin

1 reference

12 December 2020

Oligoclonal bands in CSF: twins with MS

1 reference

12 December 2020

Oligoclonal bands in multiple sclerosis: clinical-pathologic correlation

1 reference

12 December 2020

Dissociation between macrophage tumoricidal capacity and suppressive activity: analysis with macrophage-defective mouse strains

1 reference

12 December 2020

Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis.

1 reference

12 December 2020

Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells

1 reference

12 December 2020

Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b

1 reference

12 December 2020

Influence of infection on exacerbations of multiple sclerosis

1 reference

12 December 2020

Restricted T cell expression of IL-2/IFN-gamma mRNA in human inflammatory disease

1 reference

12 December 2020

Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages

1 reference

12 December 2020

Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions

1 reference

12 December 2020

Clinical viral infections and multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis: remyelination of nascent lesions

1 reference

12 December 2020

Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance

1 reference

12 December 2020

Suppression of experimental allergic encephalomyelitis by interferon

1 reference

12 December 2020

Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice

1 reference

12 December 2020

Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis.

1 reference

12 December 2020

Detection of in vivo stimulated cerebrospinal-fluid lymphocytes by flow cytometry in patients with multiple sclerosis

1 reference

12 December 2020

The inhibition of endotoxin-induced local inflammation by LDH virus or LDH virus-infected tumors is mediated by interferon

1 reference

12 December 2020

Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines

1 reference

12 December 2020

Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon

1 reference

12 December 2020

The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones

1 reference

12 December 2020

Multiple sclerosis: involvement of interferons in lesion pathogenesis

1 reference

12 December 2020

Oligodendrocyte injury is an early event in lesions of multiple sclerosis.

1 reference

12 December 2020

Enhancement of T cell cytotoxic responses by purified human fibroblast interferon

1 reference

12 December 2020

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

12 December 2020

Intermittent interferonemia and interferon responses in multiple sclerosis

1 reference

12 December 2020

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1 reference

12 December 2020

Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

1 reference

12 December 2020

Effects of interferons-alpha, -beta, and -gamma on human interleukin-2 production

1 reference

12 December 2020

Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2

1 reference

12 December 2020

Interleukin 2 induces interferon alpha/beta production in mouse bone marrow cells

1 reference

12 December 2020

Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis

1 reference

12 December 2020

Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis

1 reference

12 December 2020

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin

1 reference

12 December 2020

Macrophage activation by interferon: dissociation between tumoricidal capacity and suppressive activity

1 reference

12 December 2020

Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance

1 reference

12 December 2020

Patterns of oligodendroglia pathology in multiple sclerosis

1 reference

12 December 2020

Deactivation of macrophages by transforming growth factor-β

1 reference

12 December 2020

Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

1 reference

12 December 2020

Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells

1 reference

12 December 2020

Interferon beta augments suppressor cell function in multiple sclerosis

1 reference

12 December 2020

Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis

1 reference

12 December 2020

Prostaglandin E inhibits the production of human interleukin 2

1 reference

12 December 2020

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

12 December 2020

Interferon-beta treatment does not elevate cortisol in multiple sclerosis

1 reference

12 December 2020

Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2.

1 reference

12 December 2020

Genetic control of multiple sclerosis: increased production of lymphotoxin and tumor necrosis factor-alpha by HLA-DR2+ T cells.

1 reference

12 December 2020

Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis

1 reference

12 December 2020

Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta

1 reference

12 December 2020

Virus-induced interferon alpha/beta (IFN-alpha/beta) production by T cells and by Th1 and Th2 helper T cell clones: a study of the immunoregulatory actions of IFN-gamma versus IFN-alpha/beta on functions of different T cell populations

1 reference

12 December 2020

Human gamma interferon increases the binding of T lymphocytes to endothelial cells

1 reference

12 December 2020

Down-regulation of interferon-gamma-induced class II expression on human glioma cells by recombinant interferon-beta: effects of dosage treatment schedule

1 reference

12 December 2020

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

1 reference

12 December 2020

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1

1 reference

12 December 2020

Activated suppressor cell dysfunction in progressive multiple sclerosis

1 reference

12 December 2020

Immunological complications in multiple sclerosis patients receiving interferon

1 reference

12 December 2020

Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions

1 reference

12 December 2020

IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma

1 reference

12 December 2020

Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.

1 reference

12 December 2020

Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin

1 reference

12 December 2020

Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo

1 reference

12 December 2020

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00792613

1 reference

29 September 2017

1 reference